Filing Details
- Accession Number:
- 0001305773-17-000019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-11 19:40:46
- Reporting Period:
- 2017-01-09
- Filing Date:
- 2017-01-11
- Accepted Time:
- 2017-01-11 19:40:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1305773 | Conformis Inc | CFMS | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645522 | Philipp Lang | C/O Conformis, Inc. 28 Crosby Drive Bedford MA 01730 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-01-09 | 1,500 | $5.26 | 516,119 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-09 | 1,500 | $5.26 | 517,619 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-09 | 1,600 | $5.50 | 519,219 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-09 | 1,600 | $5.50 | 520,819 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-09 | 6,200 | $8.65 | 514,619 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-01-10 | 13,431 | $5.26 | 528,050 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-10 | 28,569 | $5.26 | 556,619 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-10 | 2,809 | $5.50 | 559,428 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-01-10 | 32,900 | $5.50 | 592,328 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-01-10 | 77,709 | $8.64 | 514,619 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-09 | 1,500 | $0.00 | 1,500 | $5.26 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-09 | 1,500 | $0.00 | 1,500 | $5.26 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-09 | 1,600 | $0.00 | 1,600 | $5.50 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-09 | 1,600 | $0.00 | 1,600 | $5.50 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-10 | 13,431 | $0.00 | 13,431 | $5.26 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-10 | 28,569 | $0.00 | 28,569 | $5.26 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-10 | 32,900 | $0.00 | 32,900 | $5.50 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-01-10 | 2,809 | $0.00 | 2,809 | $5.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 13,431 | 2021-09-27 | No | 4 | M | Direct | |
| 241,306 | 2021-09-27 | No | 4 | M | Direct | |
| 182,652 | 2022-03-27 | No | 4 | M | Direct | |
| 2,809 | 2022-03-27 | No | 4 | M | Direct | |
| 0 | 2021-09-27 | No | 4 | M | Direct | |
| 212,737 | 2021-09-27 | No | 4 | M | Direct | |
| 149,752 | 2022-03-27 | No | 4 | M | Direct | |
| 0 | 2022-03-27 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,498 | Indirect | See footnote. |
| Common Stock | 930,904 | Indirect | See footnote. |
Footnotes
- This sale was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
- The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $8.60-$8.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $8.60-$8.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The shares are held directly by the Reporting Person's children.
- The shares are held directly by the NP Irrevocable Trust udt dated 12/28/12. The Reporting Person's immediate family members are beneficiaries of the NP Irrevocable Trust udt dated 12/28/12, and the Reporting Person disclaims beneficial ownership of all shares except to the extent of his pecuniary interest therein.
- This option is fully vested.
Billionaire Hedge Funds
